Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haemophilia and Bone Loss PHILEOS Study
NCT04384341Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Jun 2020
- Primary completion
- Dec 2024
- Countries
- 5
01
Overview
Open-label trial (2 arms), sponsored by CHU Saint-Etienne. Primary endpoint: Osteoporosis defined by a T-score < -2.5. Started Jun 2020; status: completed.
Beyond the preview
Go deeper on NCT04384341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04384341.